Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam).

Kerkhof, Melissa; Roobol, Monique J; Cuzick, Jack; Sasieni, Peter; Roemeling, Stijn; Schröder, Fritz H; Steyerberg, Ewout W

Kerkhof, Melissa; Roobol, Monique J; Cuzick, Jack; Sasieni, Peter; Roemeling, Stijn; Schröder, Fritz H; Steyerberg, Ewout W.

Affiliation

Kerkhof M; Department of Urology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. 286795mk@student.eur.nl

Int J Cancer ; 127(11): 2639-44, 2010 Dec 01.

Article in En | MEDLINE | ID: mdl-20196067

Subject(s)

Patient Compliance/statistics & numerical data; Prostatic Neoplasms/mortality; Prostatic Neoplasms/prevention & control; Aged; Humans; Incidence; Male; Mass Screening/methods; Middle Aged; Models, Statistical; Neoplasm Metastasis; Netherlands/epidemiology; Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnosis; Prostatic Neoplasms/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Patient Compliance Type of study: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2010 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google